Clinician Perspectives on Monoclonal Antibody Treatment for High-Risk Outpatients with COVID-19: Implications for Implementation and Equitable Access

BACKGROUND: There is an urgent need to identify and address factors influencing uptake and equitable access to monoclonal antibody (mAb) treatment for high-risk outpatients with COVID-19. OBJECTIVE: To assess clinician knowledge, beliefs, and experiences regarding obtaining mAb treatment for eligibl...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwan, Bethany M., Sobczak, Chelsea, Beaty, Laurel, Wynia, Matthew K., DeCamp, Matthew, Owen, Vanessa, Ginde, Adit A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255528/
https://www.ncbi.nlm.nih.gov/pubmed/35790666
http://dx.doi.org/10.1007/s11606-022-07702-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255528/
https://www.ncbi.nlm.nih.gov/pubmed/35790666
http://dx.doi.org/10.1007/s11606-022-07702-2

Ejemplares similares